Skip to main content
. Author manuscript; available in PMC: 2010 Jun 21.
Published in final edited form as: Stroke. 2008 Apr 24;39(7):1952–1959. doi: 10.1161/STROKEAHA.107.508135

Table 2.

Association of plasma IL6 and CRP levels with presence of white matter lesions and brain infarcts at the 1st MRI examination

Odds Ratio (95% Confidence Interval) for association with presence of WML Odds Ratio (95% Confidence Interval) for association with presence of BI
Whites (N=3,073) Blacks (N=571) Whites (N=3,073) Blacks (N=571)
IL6 CRP IL6 CRP IL6 CRP IL6 CRP
Model 1
 1st Quartile 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent)
 2nd Quartile 1.24 (0.99; 1.55) 1.28 (1.03; 1.59) 1.87 (1.09; 3.19) 0.82 (0.49; 1.38) 1.38 (1.07; 1.78) 0.99 (0.78; 1.25) 1.05 (0.57; 1.92) 1.05 (0.58; 1.89)
 3rd Quartile 1.32 (1.05; 1.65) 1.31 (1.05; 1.62) 1.26 (0.75; 2.13) 0.89 (0.53; 1.51) 1.43 (1.10; 1.85) 1.16 (0.92; 1.47) 1.17 (0.63; 2.17) 1.07 (0.60; 1.93)
 4th Quartile 1.48 (1.18; 1.86) 1.59 (1.27; 1.98) ** 2.16 (1.26; 3.73) * 1.28 (0.74; 2.19) 1.81 (1.40; 2.33)** 1.18 (0.93; 1.49) 1.37 (0.74; 2.51) 1.45 (0.81; 2.58)
P trend 0.007 0.0006 0.02 0.37 0.0001 0.29 0.74 0.56
 Per SD (log) 1.28 (1.11; 1.47) 1.13 (1.06; 1.22) 1.55 (1.12; 2.15) 1.09 (0.93; 1.28) 1.41 (1.21; 1.63) 1.11 (1.03; 1.20) 1.32 (0.94; 1.85) 1.16 (0.98; 1.38)
Model 2
 1st Quartile 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent)
 2nd Quartile 1.22 (0.97; 1.53) 1.21 (0.97; 1.51) 1.83 (1.05; 3.18) 0.80 (0.47; 1.37) 1.35 (1.04; 1.75) 0.95 (0.74; 1.21) 1.09 (0.58; 2.04) 1.04 (0.56; 1.93)
 3rd Quartile 1.27 (1.01; 1.60) 1.20 (0.97; 1.50) 1.25 (0.71; 2.17) 0.86 (0.50; 1.48) 1.40 (1.07; 1.83) 1.10 (0.86; 1.41) 1.12 (0.58; 2.18) 1.11 (0.60; 2.04)
 4th Quartile 1.43 (1.12; 1.82) * 1.48 (1.17; 1.84) ** 2.20 (1.23; 3.90) * 1.16 (0.67; 2.04) 1.75 (1.34; 2.28)** 1.11 (0.86; 1.42) 1.37 (0.71; 2.65) 1.62 (0.85; 3.11)
P trend 0.03 0.01 0.03 0.55 0.0008 0.54 0.80 0.43
 Per SD (log) 1.24 (1.07; 1.44) 1.11 (1.03; 1.19) 1.55 (1.10; 2.19) 1.06 (0.90; 1.25) 1.37 (1.17; 1.60) 1.09 (1.01; 1.19) 1.34 (0.93; 1.93) 1.21 (1.00; 1.47)
Model 3
 1st Quartile 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent) 1 (referent)
 2nd Quartile 1.09 (0.84; 1.41) 1.15 (0.89; 1.50) 1.95 (1.02; 3.71) 0.84 (0.44; 1.61) 1.33 (0.99; 1.80) 0.96 (0.72; 1.29) 1.28 (0.62; 2.67) 0.81 (0.39; 1.66)
 3rd Quartile 1.28 (0.97; 1.67) 1.13 (0.86; 1.47) 1.22 (0.63; 2.34) 0.83 (0.43; 1.58) 1.38 (1.01; 1.87) 1.07 (0.80; 1.44) 1.19 (0.56; 2.56) 1.03 (0.51; 2.08)
 4th Quartile 1.42 (1.08; 1.87)* 1.33 (1.01; 1.75)* 2.13 (1.08; 4.20)* 0.90 (0.44; 1.86) 1.87 (1.38; 2.54)** 1.14 (0.84; 1.54) 1.68 (0.81; 3.52) 1.47 (0.70; 3.08)
P trend 0.06 0.26 0.06 0.94 0.0009 0.69 0.55 0.47
 Per SD (log) 1.23 (1.05; 1.46) 1.09 (0.99; 1.21) 1.54 (1.03; 2.30) 1.18 (0.94; 1.48) 1.46 (1.22; 1.74) 1.09 (0.99; 1.21) 1.42 (0.96; 2.11) 1.18 (0.94; 1.48)
*

P<0.05;

**

P<0.01 for comparison with 1st quartile;

P trend over quartiles; SD: standard deviation; log: logarithm-transformed biomarker plasma levels; Model 1: adjusted for age and sex; Model 2: adjusted for age, sex, current smoking, education, diastolic blood pressure, body mass index, and hypertension (MRI-defined WML); adjusted for age, sex, current smoking, systolic blood pressure, diastolic blood pressure, HDL cholesterol, body mass index, diabetes, and hypertension (MRI-defined BI). Model 3: adjusted for variables in Model 2 and excluding individuals with prevalent stroke, transient ischemic attack, coronary heart disease, and heart failure (N=2,283, Whites; N=426, Blacks). Cutoff for Quartiles of plasma IL6 in Whites and Blacks, respectively: 1st: 0.35–1.08; 0.36–1.18 pg/mL; 2nd: 1.09–1.55; 1.19–1.70 pg/mL; 3rd: 1.56–2.31; 1.71–2.58 pg/mL; 4th: 2.32–44.17; 2.59–23.37 pg/mL. Cutoff for Quartiles of plasma CRP in Whites and Blacks, respectively: 1st: 0.13–1.13; 0.16–1.47 mg/L; 2nd: 1.14–2.43; 1.49–3.45 mg/L; 3rd: 2.44–5.34; 3.46–7.86 mg/L; 4th: 5.35–143.0; 7.89–79.40 mg/L.